Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan
· Delayed Price · Currency is JPY 7,940.00
+495.00 (6.65%)
Apr 28, 2026, 3:30 PM JST
Chugai Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 452,196 | 434,012 | 387,317 | 325,472 | 374,429 | 302,995 | Upgrade
|
| Depreciation & Amortization | 33,035 | 32,535 | 31,665 | 31,740 | 31,434 | 30,868 | Upgrade
|
| Loss (Gain) From Sale of Assets | -8,027 | 4,527 | 4,377 | -21,881 | 641 | 6,342 | Upgrade
|
| Other Operating Activities | 15,151 | -190,078 | -101,510 | -180,718 | -152,074 | -104,102 | Upgrade
|
| Change in Other Net Operating Assets | -63,749 | 105,284 | 125,751 | 255,312 | -10,318 | 43,523 | Upgrade
|
| Operating Cash Flow | 441,643 | 386,280 | 447,600 | 409,925 | 244,112 | 279,626 | Upgrade
|
| Operating Cash Flow Growth | 6.84% | -13.70% | 9.19% | 67.92% | -12.70% | 36.38% | Upgrade
|
| Capital Expenditures | -66,869 | -76,273 | -50,415 | -71,948 | -62,625 | -65,969 | Upgrade
|
| Sale of Property, Plant & Equipment | 7,509 | 7,509 | -510 | 19,346 | 1,048 | 1,042 | Upgrade
|
| Sale (Purchase) of Intangibles | -42,729 | -35,306 | -1,685 | 12,850 | -8,614 | -6,897 | Upgrade
|
| Investment in Securities | 97,082 | -100,804 | -177,539 | 979 | -76,083 | -47,236 | Upgrade
|
| Other Investing Activities | 4,416 | 3,601 | 2,784 | 1,483 | 280 | 133 | Upgrade
|
| Investing Cash Flow | -591 | -201,273 | -227,365 | -37,290 | -145,994 | -118,927 | Upgrade
|
| Issuance of Common Stock | 89 | 142 | 168 | 217 | 241 | 322 | Upgrade
|
| Repurchase of Common Stock | -7 | -6 | -10 | -5 | -5 | -8 | Upgrade
|
| Common Dividends Paid | -448,001 | -299,419 | -133,249 | -131,594 | -138,220 | -98,644 | Upgrade
|
| Other Financing Activities | -518 | -8,603 | -7,915 | -7,949 | -7,657 | -9,078 | Upgrade
|
| Financing Cash Flow | -457,092 | -307,886 | -141,006 | -139,331 | -145,641 | -107,408 | Upgrade
|
| Foreign Exchange Rate Adjustments | 10,605 | 9,279 | 2,299 | 3,202 | 1,939 | 2,128 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -1 | - | - | Upgrade
|
| Net Cash Flow | -5,435 | -113,600 | 81,528 | 236,505 | -45,584 | 55,419 | Upgrade
|
| Free Cash Flow | 374,774 | 310,007 | 397,185 | 337,977 | 181,487 | 213,657 | Upgrade
|
| Free Cash Flow Growth | 6.22% | -21.95% | 17.52% | 86.23% | -15.06% | 44.37% | Upgrade
|
| Free Cash Flow Margin | 29.03% | 24.64% | 33.93% | 30.41% | 14.40% | 21.37% | Upgrade
|
| Free Cash Flow Per Share | 227.73 | 188.37 | 241.36 | 205.40 | 110.30 | 129.87 | Upgrade
|
| Cash Interest Paid | 521 | 429 | 94 | 81 | 58 | 48 | Upgrade
|
| Cash Income Tax Paid | 173,492 | 191,104 | 100,477 | 176,074 | 152,082 | 104,074 | Upgrade
|
| Levered Free Cash Flow | 308,220 | 263,045 | 338,816 | 317,041 | 148,160 | 177,704 | Upgrade
|
| Unlevered Free Cash Flow | 308,349 | 263,175 | 338,813 | 317,058 | 148,198 | 177,734 | Upgrade
|
| Change in Working Capital | -63,749 | 105,284 | 125,751 | 255,312 | -10,318 | 43,523 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.